Unilife Signs an Exclusive License Agreement with sanofi-aventis
Key Points: •Sanofi-aventis secures exclusive rights to the Unilife Ready-to-Fill Syringe for five years •Unilife to receive an upfront license fee of A$16.4 million (€10 million) fromsanofi-aventis •Unilife and sanofi-aventis to negotiate in good faith to finalise an agreement to complete industrialisation of the licensed product under which sanofiaventis will bear the industrialisation costs initially estimated at A$24 to $27 million (€15 to €17 million)
UNS Price at posting:
57.0¢ Sentiment: None Disclosure: Held